BioGaia Launch Rehydration Solution in Africa
14 Sep 2016 --- BioGaia has signed an exclusive distributor agreement with Phillips Pharma Group for the rights to sell BioGaia ProTectis drops, tablets and Oral Rehydration Solution in Kenya, Nigeria and Ghana.
The agreement will grant BioGaia access to 350 million people across seven countries in Africa, 35 percent of Africa’s population.
“I am very happy that we have signed an agreement that gives BioGaia access to Central and Eastern Africa, a market with large potential for our products,” said Axel Sjöblad, Managing Director, BioGaia, “Phillips Pharma Group is a strong and reliable partner with local presence in several important markets and I look forward to a fruitful collaboration.”
Phillips Pharma Group was established in Kenya in 1991, focusing on importing, marketing and distributing pharmaceuticals. Today the company has more than 1,000 employees and is present in seven countries around Africa, Kenya, Nigeria, Tanzania, Zambia, Uganda, Rwanda and Ghana.
The Phillips Group operations have been extended with subsidiaries specialized in surgical products, medical devices and diagnostics. Among the partners are important international pharmaceutical companies such as Novartis, Abbott, Sandoz and Menarini.
“Phillips Pharma Group, believes in a long term partnership with BioGaia and is committed to market and position its probiotics as an innovative and premium brand in the market,” said Niraj Doshi, CEO, Phillips Pharma Group Ltd, “The experience we have working close to doctors and specialists will allow us to achieve BioGaia’s expectations and goals.”
The products will be sold under the BioGaia brand and the launch is planned to start in Kenya in this year.
